@article {Woods153, author = {Scott E. Woods and Vivian Ghodsi and Amy Engel and Jeff Miller and Shama James}, title = {Serum Chromium and Gestational Diabetes}, volume = {21}, number = {2}, pages = {153--157}, year = {2008}, doi = {10.3122/jabfm.2008.02.070155}, publisher = {The Journal of the American Board of Family Medicine}, abstract = {Objective: To prospectively assess if chromium levels are different in gestational diabetics than in nondiabetic pregnant women. Therapeutic options could exist if levels are different.Methods: We conducted a 2-year prospective, gestational cohort study. The cohort included newly diagnosed pregnant patients. Two blood samples were taken, the first at consent, the second at the time of diabetes screening.Results: Five hundred eighty patients entered the cohort. One hundred fifty-five were lost to follow up and 425 patients completed the study (396 nondiabetics and 29 diabetics). The patients with gestational diabetes were significantly older, with a family history of gestational diabetes, and were significantly more likely to have been a gestational diabetic in a previous pregnancy (P \< 05). There was no significant difference between the 2 groups for chromium levels both at enrollment (0.15 {\textpm} 0.06 ng/mL vs 0.14 {\textpm} 0.03 ng/mL; P = .28) and during the second trimester (0.14 {\textpm} 0.06 ng/mL vs 0.14 {\textpm} 0.04 ng/mL; P = .82).Conclusion: Serum chromium levels do not exhibit any significant variation between gestational diabetic women and nondiabetic women when assessed prospectively.}, issn = {1557-2625}, URL = {https://www.jabfm.org/content/21/2/153}, eprint = {https://www.jabfm.org/content/21/2/153.full.pdf}, journal = {The Journal of the American Board of Family Medicine} }